Memory Training Intervention for Breast Cancer Survivors
NCT ID: NCT01497015
Last Updated: 2023-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2008-09-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim 1: Evaluate the acceptability and usefulness of the ACTIVE memory intervention among Breast Cancer Survivors (BCS).
Hypothesis 1: BCS assigned to the memory intervention arm will perceive the intervention as more acceptable and useful than BCS assigned to the attention control condition.
Aim 2: Establish preliminary efficacy of the ACTIVE memory training intervention relative to the attention control and no-contact control conditions.
Hypothesis 2: Memory training will result in greater memory enhancement immediately post and 2-months post-intervention relative to attention control or no-contact control conditions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Functional Recovery of Breast Cancer Survivors
NCT03915548
Telehealth and Memory Study
NCT04586530
Activity & Cognition After Treatment for Breast Cancer
NCT02592070
Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors
NCT01540955
Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer
NCT03277898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
memory training
memory training 10 1-hour sessions with interventionist to be delivered over 6-8 weeks
memory training
10 1-hour sessions over 6-8 weeks
speed of processing training
Speed of processing training 10 1-hour sessions delivered over 6-8 weeks
speed of processing training
10 1-hour sessions delivered over 6-8 weeks
waitlist control
Breast cancer survivors will be randomized to 1 of 3 groups: memory training, speed of process training or waitlist control
waitlist control
Breast cancer survivors will receive the speed of processing training compact disc in the mail after study completion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
memory training
10 1-hour sessions over 6-8 weeks
speed of processing training
10 1-hour sessions delivered over 6-8 weeks
waitlist control
Breast cancer survivors will receive the speed of processing training compact disc in the mail after study completion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. self-reported memory impairment and desire for treatment (to focus on BCS in greatest need);
3. first diagnosis of non-metastatic breast cancer (to control for multiple treatments or brain metastases in women with recurrent or metastatic disease);
4. ≥ 1 year post-treatment including surgery, radiation, and/or chemotherapy (reduce confounding factors related to acute effects of treatment);32
5. age ≥ 40 years (our prior studies indicate approximately 75% of BCS meet this criterion and reduce sample variability);
6. post-menopausal (majority are post-menopausal at diagnosis and reduce sample variability); and
7. able to read, write, understand, and speak English (to ensure informed consent).
Exclusion Criteria
1. substantial cognitive decline (score \< 24 on the Mini Mental State Exam (MMSE);33
2. history of stroke, encephalitis, traumatic brain injury, brain surgery, dementia, Alzheimer disease, or Parkinson disease;
3. cranial radiation therapy or intrathecal therapy;
4. current active major depression or substance abuse or history of bipolar disorder, psychosis, schizophrenia, or learning disability;
5. history of or current other cancer except for basal cell skin cancer; or
6. receiving other cognitive training (to avoid exposure to other training).
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diane Von Ah
Associate Professor, Department Chair, School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diane Von Ah, PhD, RN, CNA
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Andrew Saykin, PsyD
Role: STUDY_DIRECTOR
Indiana University
Frederick Unverzagt, PhD
Role: STUDY_DIRECTOR
Indiana University
Janet Carpenter, PhD, RN
Role: STUDY_DIRECTOR
Indiana University
Patrick Monahan, PhD
Role: STUDY_DIRECTOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
64194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.